Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grass pollen AIT tablet versus placebo for seasonal allergic rhinitis
2013-003732-72Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Oct 2013
- Countries
- 1
01
Overview
Phase 2, randomised trial of phleum pratense allergen extract in seasonal allergic rhinitis (SAR) and allergic rhinoconjunctivitis (ARC) (3 arms), sponsored by Imperial College London. Primary endpoint: Total Nasal Symptom Score after nasal allergen challenge. Started Oct 2013; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
seasonal allergic rhinitis (SAR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on 2013-003732-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003732-72.